Explore the full record of transactions filed by Ahmad Fuad, 首席财务官. Insider active across 1 company, notably Vaxart, Inc.. Aggregated, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €15k. History available since 22 June 2022. The latest transaction was disclosed on 22 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Fuad Ahmad serves as the Interim Chief Financial Officer at Vaxart, Inc. In this role, he is responsible for financial management and strategy. Vaxart, Inc. is a biopharmaceutical company specializing in vaccine development. Fuad leverages his expertise to optimize financial operations and support the company's growth.